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Abstract
Background: Hydrogen-rich saline has been reported to have antioxidant and anti-inflammatory effects and
effectively protect against organ damage. Oxidative stress and inflammation contribute to the pathogenesis and/or
development of pulmonary hypertension. In this study, we investigated the effects of hydrogen-rich saline on the
prevention of pulmonary hypertension induced by monocrotaline in a rat model.
Methods: In male Sprague-Dawley rats, pulmonary hypertension was induced by subcutaneous administration of
monocrotaline at a concentration of 6 mg/100 g body weight. Hydrogen-rich saline (5 ml/kg) or saline was
administred intraperitoneally once daily for 2 or 3 weeks. Severity of pulmonary hypertension was assessed by
hemodynamic index and histologic analysis. Malondialdehyde and 8-hydroxy-desoxyguanosine level, and
superoxide dismutase activity were measured in the lung tissue and serum. Levels of pro-inflammatory cytokines
(tumor necrosis factor-a, interleukin-6) in serum were determined with enzyme-linked immunosorbent assay.
Results: Hydrogen-rich saline treatment improved hemodynamics and reversed right ventricular hypertrophy.
It also decreased malondialdehyde and 8-hydroxy-desoxyguanosine levels, and increased superoxide dismutase
activity in the lung tissue and serum, accompanied by a decrease in pro-inflammatory cytokines.
Conclusions: These results suggest that hydrogen-rich saline ameliorates the progression of pulmonary
hypertension induced by monocrotaline in rats, which may be associated with its antioxidant and anti-
inflammatory effects.
Background
Pulmonary hypertension (PH), a syndrome that encom-
passes several diseases, is characterized by a progressive
elevation of pulmonary arterial pressure, which may ulti-
mately induce right ventricular (RV) failure and death [1].
Pulmonary hypertension, either idiopathic or secondary,
may share some of the following pathological or functional
changes, including vascular remodeling, endothelial dys-
function/increased vasoconstriction, oxidative stress and
inflammation. Among these changes, the effects of oxida-
tive stress and inflammation on PH have been investigated
intensively in recent years. Oxidative stress is characterized
by an increase in oxidants with or without a decrease in
antioxidants or antioxidant enzymes. Oxidants cause tissue
damage by mechanisms such as lipid peroxidation and
DNA damage [2]. Previous studies have suggested that
increased oxidative stress contributes to the pathogenesis
and/or development of PH [3], and that antioxidant treat-
ment ameliorates PH or PH-induced heart failure in rats
[4,5]. Furthermore, the mechanisms of inflammation in
PH include up-regulation of cytokines and infiltration of
inflammatory cells.
Current treatment for PH is limited and only provides
symptomatic relief. Therefore, it is imperative to look for
new therapeutic approach for PH. Hydrogen gas (H2) has
been applied in medical applications to prevent decom-
pression sickness [6]. Shirahata and colleagues [7] reported
that electrolyzed-reduced water, which dissolved large
amounts of H2, had the ability to protect DNA from
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any medium, provided the original work is properly cited.oxidative damage. Recently, it has been suggested that H2
has therapeutic antioxidant activity by selectively reducing
hydroxyl radicals and effectively protecting against organ
damage, such as cerebral ischemia, neonatal cerebral
hypoxia-ischemia, liver injury, lung injury and myocardial
injury induced by ischemia/reperfusion [8-12]. Moreover,
it has been reported that hydrogen-rich saline has an anti-
inflammatory effect [13].
Therefore, we hypothesized that the antioxidant and
anti-inflammatory effects of hydrogen-rich saline might
prevent the progression of PH. To test this hypothesis,
we investigated the efficacy of hydrogen-rich saline in
monocrotaline (MCT)-treated PH rats.
Methods
Animals
Male Sprague-Dawley rats, weighing 200-220 g, were
provided by the Experimental Animal Center of Shan-
dong University of Traditional Chinese Medicine (Shan-
dong, China). Rats were housed with free access to food
and water under a natural day/night cycle. Rats were
acclimated for 7 days before any experimental proce-
dures. All rats received humane care according to the
Guide for the Care and Use of Laboratory Animals by
the Chinese Academy of Sciences.
Drugs and materials
Hydrogen-rich saline was prepared as previously
described [14]. Briefly, hydrogen was dissolved in nor-
mal saline for 2 h under high pressure (0.4 MPa) to the
supersaturated level using a self-designed, hydrogen-
rich water-producing apparatus. The saturated hydro-
gen-saline (250 ml) was stored under atmospheric pres-
s u r ea t4 ° Ci na na l u m i n u mb a gw i t h o u td e a dv o l u m e .
Hydrogen-rich saline was freshly prepared every week
to ensure a constant concentration of greater than 0.6
mM. Monocrotaline was purchased from Wako Pure
Chemical Industries, Ltd.(Osaka Japan). Malondialde-
hyde (MDA) and superoxide dismutase (SOD) assay
reagents were obtained from Nanjing Jiancheng Bioen-
gineering Institute (Nanjing, China). Tumor necrosis
factor-a (TNF-a), interleukin-6 (IL-6) and 8-hydroxy-
desoxyguanosine (8-OHdG) Enzyme-Linked Immuno-
sorbent Assay (ELISA) kits were purchased from Shang-
hai Bluegene Biotech Co., Ltd. (Shanghai, China).
Experimental design
Rats were divided randomly into the following groups of 10
rats each: (1) control group, in which rats received an equal
volume of vehicle, followed by saline from day 1 to day 21;
(2) MCT-treated group, in which rats received a single sub-
cutaneous injection of MCT (dissolved in 1N HCL buf-
f e r e dt op H7 . 0w i t h1 NN a O H[ 1 5 ] )a tad o s eo f6m g / 1 0 0
g body weight, followed by saline from day 1 to day 21; (3)
hydrogen-rich saline 2-week group, in which rats received
hydrogen-rich saline from day 8 to day 21 after MCT injec-
tion; (4) hydrogen-rich saline 3-week group, in which rats
received hydrogen-rich saline from day 1 to day 21 after
MCT injection. Either 5 ml/kg hydrogen-rich saline or the
same volume of vehicle (saline) was administrated once
daily by intraperitoneal (i.p.) injection. All the experiments
were approved by the Animal Care Ethics Committee of
Taishan Medical University (Taian China).
Hemodynamic studies
On day 22, rats were anesthetized with 10% chloral hydrate
(0.4 ml/100 g body weight, i.p.) and placed in a supine
position. According to Sun’s method [16], MP150 system
(BIOPAC, USA) was applied in our experiments. Briefly, a
polyethylene catheter was introduced into the right ventri-
cle through the jugular vein to measure right ventricular
systolic pressure (RVSP). Peak rates of RV pressure rise
(dP/dt max) and pressure fall (dP/dt min) were measured
as well. The catheter was advanced to the pulmonary artery
to measure mean pulmonary artery pressure (mPAP). After
hemodynamic measurements, the thorax was opened,
blood was taken from the heart for serum preparation, and
lung and heart were processed for histological evaluation
or frozen in liquid nitrogen for further analysis.
Measurement of RV hypertrophy[17]
Heart was dissected and weighed, and the ratio of RV
weight to left ventricle plus septum weight (RV/[LV+S]
weight) was measured and calculated.
Histopathological observations
For histopathological observations, specimens of the
right lower lung were harvested and flushed with nor-
mal saline, fixed in 4% paraformaldehyde for 24 h, and
embedded in paraffin. Sections of 4 μm were stained
with hematoxylin-eosin (H-E) for light microscopy.
Determination of TNF-a and IL-6 levels in the serum
Levels of TNF-a and IL-6 in serum were measured with
commercial ELISA kits following the instructions of the
manufacturer. Absorbance was read on a microplate
reader and the concentrations were calculated according
to the standard curve.
Measurement of 8-OHdG, MDA and SOD in lung tissues
and serum
Left lung tissues (100 mg, wet wt.) were homogenized in
1 ml saline at 4°C. The homogenates were centrifuged at
2000 rpm at 4°C for 15 min. The MDA content and SOD
activity in both supernatant and serum were determined
by chemical assay according to the manufacturer’s
instructions. Levels of 8-OHdG in serum and lung tissue
were measured with ELISA kits. Protein concentration
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were expressed as microgram of protein.
Statistics
Results were expressed as mean ± S.D. All data were
statistically analyzed with SPSS11.5 (SPSS Inc., Chicago,
IL, USA). Statistical comparisons were performed by
one-way analysis of variance (ANOVA) followed by Stu-
dent-Newman-Keuls’s post hoc test. A P value less than
0.05 was considered statistically significant.
Results
Hydrogen-rich saline treatment improved hemodynamics
Results of hemodynamic studies in the four groups are
shown in Figure 1. Compared with the control group,
mPAP, RVSP, RV dP/dt max and dP/dt min in rats
challenged with MCT in the MCT-treated group
increased significantly (P <0 . 0 1 ) ,i n d i c a t i n gt h a tr a t s
developed severe PH. Hydrogen-rich saline treatment
for either 2 or 3 weeks attenuated the effects of MCT,
suggesting that mPAP, RVSP, RV dP/dt max and dP/dt
min were decreased significantly compared with the
MCT group (P < 0.05).
Hydrogen-rich saline treatment ameliorated the damage
to lung tissue and reversed RV hypertrophy
In the lungs of MCT-treated rats, the pulmonary artery
wall was significantly thicker, the medial smooth muscle
layer was increased significantly, and the lumen
appeared stenosed or occluded. Large amounts of
Figure 1 Hydrogen-rich saline improved hemodynamics in MCT-induced PH. mPAP (A), RVSP (B), RV dP/dt max (C) and RV -dP/dt min (D).
*P < 0.05, **P < 0.01.
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all of these pathological changes were decreased by the
hydrogen-rich saline treatment (Figure 2A).
With regard to RV hypertrophy, the ratio of RV
weight to LV+S weights in the MCT group (0.35 ± 0.04,
P < 0.01 versus the control group) increased significantly
compared with the control group (0.22 ± 0.03), indicat-
ing that RV hypertrophy developed as a consequence of
increased pulmonary pressure. After 2 or 3 weeks of
hydrogen-rich saline treatment, the ratio of RV weight
to LV+S weights fell significantly to 0.31 ± 0.04 (P <
0.05 versus the MCT group) and 0.30 ± 0.03 (P <0 . 0 5
versus the MCT group). These data showed that hydro-
gen-rich saline could reverse MCT-induced RV hyper-
trophy (Figure 2B).
Hydrogen-rich saline treatment reduced the TNF-a and
IL-6 levels in serum
ELISA detection showed that the levels of TNF-a and
IL-6 in the serum were markedly increased in the MCT
group (496.21 ± 53.73 pg/ml and 339.38 ± 20.75 pg/ml,
respectively) compared with the control group (275.65 ±
32.31 pg/ml and 220.13 ± 25.01 pg/ml, respectively).
Hydrogen-rich saline treatment for 2 weeks (305.85 ±
5 0 . 4 9p g / m la n d2 5 5 . 1 1±3 4 . 5 9p g / m l ,r e s p e c t i v e l y )o r
3 weeks (293.17 ± 51.26 pg/ml and 241.00 ± 23.43 pg/
ml, respectively) reduced the elevation of TNF-a and
IL-6 (Figure 3).
Hydrogen-rich saline treatment decreased MDA and 8-
OHdG concentrations and increased SOD activity in
serum and lung tissues
Concentrations of MDA and 8-OHdG in serum and
lung tissue from the MCT group were higher and SOD
activity was lower than in control group. It was noted
that hydrogen-rich saline treatment for either 3 or 2
weeks significantly decreased the MDA and 8-OHdG
levels and increased SOD activity compared with the
MCT group (Figure 4).
Discussion
This study demonstrated that hydrogen-rich saline treat-
ment could prevent the development of PH and reverse
RV hypertrophy induced by MCT in a rat model. This
observation was supported by the results from hemody-
namic studies and histological findings. In addition,
hydrogen-rich saline decreased MDA and 8-OHdG
levels and increased SOD activity in lung tissue and
serum, accompanied by a reduction of various cytokines
(TNF-a, IL-6).
Monocrotaline, a pyrrolizidine alkaloid, has no intrinsic
activity. In the liver, it is transformed by monooxygenase
to bioactive monocrotaline pyrrole, which selectively
injures the vascular endothelium of lung vessels.
Progressive pulmonary vasculitis leads to increased vas-
cular resistance and a gradual increase in arterial pres-
sure beginning approximately 7 days after a single dose
of MCT [18]. In our study, the rat model mimics several
aspects of both primary and secondary human PH,
including vascular remodeling, proliferation of pulmon-
ary arterial smooth muscle cells, oxidative stress,
endothelial dysfunction, upregulation of inflammatory
cytokines, and leukocyte infiltration [19]. A group treated
with hydrogen-rich saline one week after MCT adminis-
tration was included in our study, in order to avoid hav-
ing the antioxidant activity of hydrogen-rich saline
interfere with the transformation of MCT in the liver.
Based on the results, we can presume that hydrogen-rich
saline had no effect on this process. Furthermore, we
have also measured the hemodynamic and RV hypertro-
phy index of rats at one week after MCT administration
with or without giving hydrogen-rich saline, and found
that only mPAP increased slightly compared with control
rats and hydrogen-rich saline had no effect in just one
week (data not shown). So we selected three weeks after
MCT administration as the end-point of our experiment.
Previous studies have focused on the effects of hydro-
gen-rich saline on organ damage been induced by ische-
mia/reperfusion. However, the effect of hydrogen-rich
saline on PH remains unclear. In our study, prevention
of progression of PH was observed with hydrogen-rich
saline therapy, which also reduced adaptive hypertrophy
of the right ventricle. Structural changes observed in
MCT-induced pulmonary hypertension also were atte-
nuated by hydrogen-rich saline treatment, as shown in
our histopathological study. Current research indicates
that inflammation contributes to the development of PH
[20]. In our animal model of PH, the amount and activ-
ity of several inflammatory cells were increased, includ-
ing macrophages, and neutrophils. TNF-a and IL-6, the
signaling molecules, were released from activated
macrophages and neutrophils, and exhibited an amplify-
ing effect on the inflammatory response. Serum TNF-a
and IL-6 levels were upregulated significantly in the
MCT-treated group, while the serum TNF-a and IL-6
levels were down-regulated significantly by treatment
with hydrogen-rich saline. These results suggest that the
effects of hydrogen-rich saline on PH might be mediated
by depression of TNF-a and IL-6, and that hydrogen-
rich saline also has anti-inflammatory activity.
There is solid evidence that oxidative injury to the
pulmonary vascular endothelium in MCT-treated rats
precedes the progression of PH [3,21]. 8-Hydroxy-deox-
yguanosine (8-OHdG) is a product of DNA oxidative
damage caused by reactive oxygen species, and the level
can not be influenced by diet or cell renewal. Therefore,
8-OHdG might be a new biomarker to assess
DNA oxidative damage and oxidative stress [22].
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Page 4 of 8Figure 2 Representative photomicrographs of right lower lung sections and RV hypertrophy index. Lung sections in the control group
showed normal architecture. Lung sections from the MCT-treated group showed tissue damage characterized by a thicker pulmonary artery
wall, lumen stenosis, and inflammatory cell infiltration. Lung sections from rats treated with hydrogen-rich saline (5 ml/kg once daily for 2 or 3
weeks) showed significantly less histological alteration. Sections were stained with H-E (200×) (A). Administration of hydrogen-rich saline
significantly reduced RV hypertrophy compared to the MCT-treated group (B). *P < 0.05, **P < 0.01.
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Page 5 of 8Figure 3 Effects of hydrogen-rich saline treatment on serum levels of TNF-a and IL-6. Administration of hydrogen-rich saline (5 ml/kg
once daily for 2 or 3 weeks) significantly reduced the elevation of TNF-a (A) and IL-6 (B) in MCT-induced PH. *P < 0.05, **P < 0.01.
Figure 4 Changes in 8-OHdG and MDA levels, and SOD activity in serum and lung tissue. Hydrogen-rich saline treatment (5 ml/kg once
daily for 2 or 3 weeks) significantly decreased the 8-OHdG (A and B) and MDA (C and D) levels and increased SOD (E and F) activity in serum
and lung tissues. *P < 0.05, **P < 0.01.
Wang et al. Respiratory Research 2011, 12:26
http://respiratory-research.com/content/12/1/26
Page 6 of 8Malondialdehyde is the ultimate product of unsaturated
lipid peroxidation. The measurement of malondialde-
hyde in the blood may provide information on an
excessive generation of free radical-induced membrane
injury. Superoxide dismutase, an important antioxidant
enzyme in the regulation of oxidative tissue damage,
may catalyze the dismutation of two superoxide radicals
to hydrogen peroxide and oxygen. In this study, we
found that 8-OHdG and MDA levels were increased
and SOD activity was decreased in lung tissue and
serum in the MCT-treated group compared to the con-
trol group. In contrast, hydrogen-rich saline treatment
significantly decreased the 8-OHdG and MDA content
and increased SOD activity, consistent with its anti-oxi-
dative effect.
Conclusions
This study shows that hydrogen-rich saline treatment
ameliorates the progression of PH induced by MCT in
rats, which may be associated with its anti-inflammatory
and antioxidant effects. Our findings suggest that hydro-
gen-rich saline may be beneficial for the treatment of
PH. Future studies are needed to examine (1) the effects
of hydrogen-rich saline is preventive, therapeutic, or
both and time-course analysis would be needed and (2)
the detailed molecular mechanism of hydrogen-rich sal-
ine on PH.
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